KAO
2.5
237.8%
CTD
2.25
-86%
VR8
0.027
92.9%
STG
0.145
-37%
AM7
0.065
62.5%
CHM
0.008
-27.3%
PR2
0.068
58.1%
REG
4.54
-27%
IRD
0.011
57.1%
GTN
0.195
-26.4%
WSI
0.085
51.8%
ARO
0.003
-25%
GGM
0.25
47.1%
BLU
0.003
-25%
WEC
0.305
41.9%
AIH
0.41
-21.2%
SOP
0.075
41.5%
SEQ
0.071
-20.2%
AS2
0.007
40%
BNL
0.004
-20%
EXR
0.065
35.4%
CCE
0.2
-20%
TET
0.375
33.9%
EVR
0.004
-20%
SER
0.2
33.3%
SIS
0.004
-20%
RAP
0.03
30.4%
IRI
0.29
-19.4%
NAG
0.013
30%
MX1
0.022
-18.5%
C29
0.022
29.4%
BST
0.315
-18.2%
XRA
0.29
28.9%
TTT
0.14
-17.6%
BAP
0.875
28.7%
TRJ
0.17
-17.1%
AHL
1.58
27.9%
ACS
0.29
-17.1%
FTI
0.8
27%
GBL
0.015
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CYC Signed first U.S. contract with Duke University

Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts